It showed for the first time to our knowledge that HER2 overexpression alters expression of multiple GPCRs in breast cancer cells and demonstrated that Gi/o-GPCRs, the largest subset of GPCRs, promote HER2-induced breast cancer formation and progression in a genetic mouse model of HER2+ breast cancer. Here, ERBB2 is linked to breast cancer.